Table 4

Description of the sample (n=197) in individuals; medication

Medication	Female (n)	%	Male (n)	%	Total (n)	%	Χ²
Cardiac and vessel medicine
Anticoagulant	41	20.8	26	13.2	67	34.0	p=0.164
Antithrombotic	29	14,7	28	14.2	57	28.9
Beta blocker	57	28.9	41	20.8	98	49.7
Diuretic	45	22.8	32	16.2	77	39.1
Calcium channel blocker	27	13.7	31	15.7	58	29.4
Angiotensin-converting enzyme-blocker	38	19.3	47	23.9	85	43.1	p=0.018
Statin	40	20.3	35	17.8	75	38.1
Diabetes medicine
Oral diabetes medicine	16	8.1	21	10.7	37	18.8	p=134
Insulin	12	6.1	30	15.2	42	21.3	p<0.001
Psychopharmaceuticals
Dementia medicine	16	8.1	6	3.0	22	11.2	p=0.066
Antidepressant	14	7.1	11	5.6	25	12.7
Benzodiazepine	13	6.6	10	5.1	23	11.7
Sleeping pills	23	11.7	12	6.1	35	17.8	p=0.135
Analgesia (mild)	57	28.9	31	15.7	88	44.7	p=0.008
Opiates	18	9.1	12	6.1	30	15.2
Immune system medicine
Cancer medicine	2	1.0	3	1.5	5	2.5
Immunosuppressive	11	5.6	4	2.0	15	7.6	p=0.124
Cortisone per oral	12	6.1	4	2.0	16	8.1	p=0.083
Cortisone cream	4	2.0	0	0.0	4	2.0	p=0.064
Supplements
Thyroxin	16	8.1	3	1.5	19	9.6	p=0.006
Calcium supplement	46	23.4	16	8.1	62	31.5	p<0.001
Folic acid	7	3.6	3	1.5	10	5.1
B₁₂ supplement	11	5.6	12	6.1	23	11.7
Vitamin D supplement	44	22.3	22	11.2	66	33.5	p=0.013
Nutrition supplement	6	3.0	2	1.0	8	4.1
Magnesium supplement	7	3.6	4	2.0	11	5.6
Vitamin K supplement	11	5.6	9	4.6	20	10.2
Other
Inhaler/nebuliser	26	13.2	16	8.1	42	21.3
Proton pump inhibitor	39	19.8	20	10.2	59	29.9	p=0.030
Urine medicine	8	4.1	12	6.1	20	10.2
Skin cream	19	9.6	10	5.1	20	10.2	p=0.190